This made us wonder if ALS-T2DM serum drives disorganized [Ca2+]i dynamics and impaired insulin secretion in islets, thereby accounting for aberrant glucose homeostasis often observed in ALS patients. Here, INS is linked to type 2 diabetes mellitus.